National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries
Felix Teufel, Pia Roddewig, Maja E. Marcus, Michaela Theilmann, Glennis Andall‐Brereton, Krishna Kumar Aryal, Sina Azadnajafabad, Pascal Bovet, et al. · Nature Communications · Aug 4, 2025
Given rising diabetes prevalence globally, access to diabetes treatments is gaining urgency. Yet, it remains unknown which glucose-lowering medication types people with diabetes across low- and middle-income countries (LMICs) use. In this cross-sectional analysis, we pooled nationally representative data of 223,283 adults aged ≥25 years in 62 LMICs from 2009 to 2019. We found that 51.9% [95%-CI: 49.6%, 54.2%] of 21,715 individuals with diabetes were undiagnosed. Among individuals with diagnosed diabetes, 18.6% [95%-CI: 14.5%, 23.4%] reported using no glucose-lowering medication, 57.3% [95%-CI:...